Document is current
Any future updates will be listed below
-
Authors
Favoreto, Michael Willian
de Oliveira de Miranda, Amanda
Matos, Thalita P.
de Castro, Andrea dos Santos
de Abreu Cardoso, Mylena
Beatriz, Julia
Collantes-Acuña, Jenny
Reis, Alessandra
Loguercio, Alessandro Dourado
- License Information
-
More Information
Article History
Received: 10 June 2024
Accepted: 23 October 2024
First Online: 4 December 2024
Declarations
:
: The clinical investigation was approved (protocol # 5.344.060) by the scientific review committee and by the committee for the protection of human participants of the Tuiuti University of Paraná (Curitiba, PR, Brazil). The study methodology was conducted in agreement with the Helsinki Declaration guidelines. All participants were informed of the nature and objectives of the study and the informed consent was obtained from all subjects before beginning of the study. This means that all subjects signed and agree to participate of the present clinical trial. It was registered in the Brazilian Clinical Trials Registry (RBR-8txr4fw; Registration Date: 26/05/2022).
: Not applicable.
: The authors declare no competing interests.
